Services for people with ankylosing spondylitis in the UK—a survey of rheumatologists and patients
Open Access
- 18 March 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 50 (11) , 1991-1998
Abstract
Objective. To investigate the services offered to patients with AS in the UK in 2010. Methods. Two thousand non-health-care professional members of the National Ankylosing Spondylitis Society (NASS) were sent a questionnaire asking about their experiences surrounding diagnosis, treatment and access to therapies (response rate 40%). A separate questionnaire was sent to a consultant rheumatologist in every acute NHS trust in the UK, asking about services offered to patients with AS (response rate 68%). Results. Overall, there was a mean diagnostic delay of 8.57 years. Almost one-third (32.2%) of patients were not reviewed in secondary care. Non-attendance was associated with increasing age and longer disease duration. Twenty per cent of patients were taking anti-TNF drugs, but 18.8% of departments reported that their ability to give anti-TNF therapy was restricted (64% reported primary-care trust rationing and 14% lack of staff). Almost all rheumatology departments had access to MRI, but 70.9% still used X-ray radiographs as their first-line investigation. A minority (5.6%) of patients reported they had never seen a physiotherapist, but less than one-third could self-refer for treatment during a flare. Conclusion. This is the first study to explore the services available to people with AS in the UK. Almost one-third of patients are not seen in rheumatology departments and therefore may be under-treated. For those who are seen, access to anti-TNF drugs and other therapies remains an issue.Keywords
This publication has 20 references indexed in Scilit:
- Impact of ankylosing spondylitis on work and family life: Comparisons with the US populationArthritis Care & Research, 2008
- Influence of biologic therapy on return to work in people with work disability due to ankylosing spondylitisRheumatology, 2007
- Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trialArthritis & Rheumatism, 2006
- Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 yrs of treatment with the anti-tumour necrosis factor agent infliximabRheumatology, 2005
- Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo‐controlled trial (ASSERT)Arthritis & Rheumatism, 2005
- Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trialArthritis & Rheumatism, 2003
- Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitisRheumatology International, 2003
- Ankylosing spondylitis: introductory comments on its diagnosis and treatmentAnnals of the Rheumatic Diseases, 2002
- Work disability among people with ankylosing spondylitisArthritis & Rheumatism, 2001
- Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donorsArthritis & Rheumatism, 1998